Home › Funds › WEXFORD CAPITAL LP › PTHS

WEXFORD CAPITAL LP position in PTHS

PELTHOS THERAPEUTICS INC · Health Care

WEXFORD CAPITAL LP reported holding 84,616 shares of PTHS (PELTHOS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.23% of its reported portfolio and ranking #43 among its reported holdings. WEXFORD CAPITAL LP has disclosed PTHS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)84.62K sh
Reported value held$1.78M
Portfolio Weight0.23%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How WEXFORD CAPITAL LP's PTHS position evolved

WEXFORD CAPITAL LP first disclosed a stake in PTHS in Q2 2026 at 22,364 shares (US$632K). The position peaked in Q3 2026 at 84,616 shares, worth US$1.8M. Across 2 filings, WEXFORD CAPITAL LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 84,616 shares valued at US$1.8M — an increase of 62,252 shares quarter over quarter.. Notable position changes include a 278% increase in Q3 2026 (shares fell 65% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 22.36K $632.01K New
Q3 2026 84.62K $1.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTHS and 13F data

PTHS (PELTHOS THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in PTHS — the largest reported positions include Ikarian Capital, LLC (US$7.3M), Murchinson Ltd. (US$6.5M), AIGH Capital Management LLC (US$5.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTHS

All PTHS fund holders →

FAQ

How long has WEXFORD CAPITAL LP held PTHS?

WEXFORD CAPITAL LP has disclosed PTHS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is WEXFORD CAPITAL LP's current position in PTHS?

As of Q3 2026, WEXFORD CAPITAL LP holds 84.62K shares of PTHS (PELTHOS THERAPEUTICS INC), valued at $1.78M, representing 0.23% of its reported portfolio and ranking #43.

Has WEXFORD CAPITAL LP been buying or selling PTHS?

In the latest 13F filing (Q3 2026), WEXFORD CAPITAL LP increased its position in PTHS. The position peaked in Q3 2026 at 84.62K shares.

Which other funds hold PTHS?

Other major institutional holders of PTHS include Ikarian Capital, LLC, Murchinson Ltd., AIGH Capital Management LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.